Spero Therapeutics, Inc. (SPRO)
NASDAQ: SPRO · Real-Time Price · USD
2.680
+0.040 (1.52%)
At close: Apr 16, 2026, 4:00 PM EDT
2.660
-0.020 (-0.75%)
After-hours: Apr 16, 2026, 7:44 PM EDT
Spero Therapeutics Stock Forecast
Stock Price Forecast
There have not been any analyst price target forecasts for Spero Therapeutics in the last 12 months.
Price Target: n/a
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Spero Therapeutics.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 1 | 2 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +86.57% | Jan 30, 2025 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $5 | Buy → Hold | Downgrades | $5 | +86.57% | Dec 20, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +86.57% | Dec 2, 2024 |
| TD Cowen | TD Cowen | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 18, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Nov 15, 2024 |
Financial Forecast
Revenue This Year
816.00K
from 66.80M
Decreased by -98.78%
Revenue Next Year
3.26M
from 816.00K
Increased by 300.00%
EPS This Year
0.68
from 0.15
Increased by 355.60%
EPS Next Year
-0.69
from 0.68
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 840,000 | 3.4M | |
| Avg | 816,000 | 3.3M | |
| Low | 784,000 | 3.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -98.7% | 311.8% | |
| Avg | -98.8% | 300.0% | |
| Low | -98.8% | 284.3% |
EPS Forecast
| EPS | 2026 | 2027 |
|---|---|---|
| High | 0.70 | -0.71 |
| Avg | 0.68 | -0.69 |
| Low | 0.66 | -0.67 |
EPS Growth
| EPS Growth | 2026 | 2027 |
|---|---|---|
| High | 369.0% | - |
| Avg | 355.6% | - |
| Low | 337.7% | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.